‘I had to sprint home from a first date': the truth about romance during hay fever season
It's 3pm on a warm early summer's day. You're in the park, a picnic basket beside you, watching your date tuck into an ice-cream. Birds are singing, children are chuckling playfully nearby. Things are going well: your date's handsome, kind and the conversation is good. But something's wrong. It starts as a tickle in the back of the throat. Then your eyes start itching and soon your nose is streaming. Suddenly, you're sneezing uncontrollably and, hang on, are you … crying? The date you're with looks at you sympathetically – poor thing – and you quietly wish for the ground to swallow you up.
It's not an uncommon scenario. In the UK, it's estimated that about 10 million people suffer from hay fever. Whenever we hit a patch of extended sunny weather, it's often caveated with warnings of impending so-called 'pollen bombs', when lots of plants release more pollen than usual all at the same time. While the warmer climes are welcome (and perfect date weather), this also means that if you're a hay fever sufferer, life is about to get complicated.
But what's actually happening when you're struck by an attack? 'Your immune system produces an allergic antibody that is specific to the things you are allergic to – in this case, pollen,' says Prof Adam Fox, one of the UK's leading specialists in allergies. 'It circulates in your blood and attaches to cells called 'mast cells' in the lining of the nose, mouth and eyes. When you breathe in pollen, it's recognised by these antibodies and it sticks to them – the mast cell then releases granules of histamine stored inside it.'
This is, of course, usually expelled as a sneeze – something which has, amusingly, been regarded suspiciously throughout history (in the middle ages people thought a sudden sneeze was a warning that you were close to evil, while in Japan and China it's thought that if you sneeze randomly, it means someone is talking about you).
'I have a very full-on sneeze,' says Hannah Lyons, 30. 'It's loud and often goes on and on – I'll have 10 sneezes in a row, particularly if hay fever is the cause. I often find myself apologising after a sneezing fit. It's embarrassing! I've had hay fever for the last five years or so – it came on suddenly one summer and I was shocked by just how debilitating it can be. I have to wear sunglasses outside in the spring and summer now or my eyes get unbearably itchy.'
Hay fever-proofing doesn't just extend to eyewear for Hannah, who is single, but her dating life, too. 'I once had a sneezing fit so bad on a date that I had to go home,' she says.
'It might sound trivial but it does properly impact my life when it's bad. The guy I was with at the time of the fit had never had hay fever, so he just looked at me like I was mad, while I couldn't stop sneezing. I eventually – between sneezes – told him I needed to go home to get inside and ran off. We didn't see each other again.'
If you're a hardcore hay fever sufferer, then precautions, particularly when it comes to dating and meeting new people, are standard. 'It's tricky,' says Katie*, 32. 'I'm in an open relationship and last summer was my first time properly dating in that way. I was due to meet up with a date and because I suffer so badly with hay fever, and have done since I was a kid, I warned her beforehand. I wrote her a proper message to say that my eyes might end up bloodshot and teary at some point – we were grabbing coffee and going for a walk in a park, so I think she was quite baffled. As expected, I did end up with weepy eyes. We went on a few more dates before we decided to stay just friends and it ended up becoming a running joke that I was always 'crying'.'
This year, Katie has beefed up her hay fever precautions. 'I have an air filter in my bedroom and I'll be keeping all the windows shut and running the fan throughout the summer. If I can manage my hay fever in my flat, I feel I'm better equipped to manage it outside too. When the pollen count is high, I tend to use a nasal spray each day, regardless of whether I'm feeling symptoms or not**. If you're dating outside – which I plan to this summer – it really is something you have to think about.'
Similarly, Hannah is taking action to try to alleviate any symptoms and has recently started using a spray. 'I use Beconase specifically – it can work even better if you start using it before the pollen count is super high**. I often think if I'd had a nasal spray I might not have had to sprint away from that first date.
'With a brand new summer, one hopefully filled with dates, not having to worry as much about hay fever symptoms feels joyful. And isn't that how dating is supposed to feel?'
* not her real name
Buy Beconase now on Amazon
Beconase Hayfever Relief for Adults 0.05% Nasal Spray contains beclometasone dipropionate. For the treatment of hayfever in adults aged 18 and over. Always read the leaflet.
** Beconase Hayfever contains beclometasone dipropionate. For the prevention and treatment of allergic rhinitis, including hayfever, in adults aged 18 and over. Always read the leaflet.
Disclaimer: Prof Adam Fox does not endorse Beconase
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Telegraph
28 minutes ago
- Telegraph
NHS boss claims Nigerian mother got the ‘black service'
An NHS boss has claimed his Nigerian mother received the 'black service, not an NHS service' after dying from suspected lung cancer. Lord Victor Adebowale, chairman of the NHS Confederation, which represents all health organisations, said the death of his 92-year-old mother was 'undignified'. His mother Grace, who worked as an NHS nurse for 45 years, died in January, possibly from lung cancer, but it was not detected until after she died. Lord Victor said there were 'too many situations where people that look like me and shades of me don't get the service'. 'It was not the dignified death that we would have wanted for her. It wasn't the death she deserved,' he told the NHS ConfedExpo conference in Manchester. 'So it makes me clear about the need to address the inequity. I think she got a black service, not an NHS service.' Mrs Adebowale emigrated from Nigeria to Scotland in the 1950s and worked as a nurse across mental health, maternity and acute care, during her career. Lord Victor, who grew up in Wakefield, said that he did not want to blame anyone for her death as the details were not yet clear, but he said that he wanted to highlight a 'systematic problem'. 'She lived to the age of 92 and you may think, 'well, she had a good old innings', but for a lot of those years she was in some discomfort, and it looks like she died from cancer,' he said. 'It's still the case that if you look like me, you're more likely to discover that you've got cancer in A&E, and that for me is an example of two different services.' 'Black people have worse outcomes' He added: 'I used the phrase 'black service'... you only have to look at the stats – across all the major disease categories that we talk about, black people have a worse experience and worse outcomes – we've known that for years, I'm not saying anything new.' He said his mother was an example of a wider issue and he was 'sick of it not changing like everyone else, and I'm close enough to it to know that it happens'. He said there was nothing in his mother's medical records to suggest she had cancer, and that she had gone to A&E in 'poor condition' at a hospital that 'was really struggling when she went in'. Lord Victor said his sister had to argue for their mother to be given a room but that they had not found the reason for her death yet. 'We haven't got to the bottom of it, and that's why I'm not blaming anybody, and I don't want to, but I can talk about my experience and my observation of what happened to my mum,' he said. 'How does that happen? I know it does happen. People have chronic diseases and people don't know and they die of them – I know it's more likely to happen if you're black, it's also more likely to happen if you're poor.' Of his mother, whose full name was Grace Amoke Owuren Adebowale, and who worked in various nursing sectors including mental health, acute care and maternity, he said: 'If you are a nurse, it is what you are, it's what you're born to do.' He went on: 'It is not acceptable that someone who looks like me, on average waits 20 minutes longer in A&E than white patients.' Kate Seymour, head of external affairs at Macmillan Cancer Support, said the story highlighted 'the heartbreaking reality for some when it comes to accessing cancer care in this country'. 'It is categorically unacceptable that some people with cancer are having worse experiences simply because of who they are or where they live. The Government in England has a unique opportunity in its upcoming cancer plan to revolutionise cancer care,' she said. An NHS spokesperson said: 'Everyone – no matter their background – should receive the best NHS care possible. 'That's why we are working across the NHS to ensure that happens – from improving access to cancer diagnosis and treatment, to expanding health checks for Black and Asian communities and increasing uptake of blood pressure and cholesterol medication in under-served groups. 'But we know there is much more to do, and tackling health inequalities will form an important part of the upcoming 10 Year Health Plan.'
Medical News Today
31 minutes ago
- Medical News Today
Celiac disease: Is an easier way to diagnose it on the horizon?
Could a blood test diagnose celiac disease without the need to trigger symptoms? Image credit: Alvaro Lavin/Stocksy. Celiac disease has to do with an abnormal immune response of the body to gluten. Experts are interested in the best ways to test for celiac disease. A recent study discovered that a blood test called WBAIL-2 could aid in diagnosing celiac disease and even contribute to biopsy-free diagnosis. Celiac disease occurs when someone's immune system responds abnormally to gluten. Efforts to improve celiac disease diagnosis are ongoing. A study recently published in Gastroenterology evaluated the effectiveness of using a blood test that measures the cytokine interleukin-2 to diagnose celiac disease. The study's results indicated that the test to be highly effective for celiac disease diagnosis, even for people following a gluten-free diet. The test could offer another option to help with celiac disease diagnosis — importantly, one that would not require triggering symptoms to confirm the disease. The authors of the current study note that there is often a delay or lack of diagnosis when it comes to celiac disease. Diagnosis usually involves people having to eat gluten and get biopsies of the small intestine. Celiac disease also has to do with the response of a group of immune cells, CD4+ gluten-specific T-cells. For this study, researchers wanted to determine if the use of a blood test that measures interleukin-2 — a protein produced by some T-cells — release could help to accurately diagnose celiac disease. This research involved a total of 181 adult participants between 18 and 75 years old. Of these participants, 88 had celiac disease, and others were controls. Among controls, 32 participants had a non-celiac gluten sensitivity and were on a gluten-free diet. The rest were healthy controls who did not have gluten sensitivity. All participants provided blood samples, and researchers collected data on medications and medical history. A subset of participants, including healthy controls, participants with non-celiac gluten sensitivity, and treated celiac disease, went on a gluten-free diet for four weeks or more and then consumed gluten for 'a single-dose open-label gluten challenge.' Some participants with treated celiac disease also did an oral gluten challenge that lasted 3 days. If participants underwent the oral gluten challenge, they used diaries to keep track of their symptoms. Researchers utilized a blood test called a WBAIL-2 assay, which measures the release of interleukin-2 in vitro after adding gluten peptides. In general, the test was able to effectively confirm celiac disease, with higher concentrations and fold change of interleukin-2 in participants who had celiac disease. However, the results were less sensitive for participants with a certain, less common genotype. Analysis results also found that the WBAIL-2 assay correlated with age and the number of years participants had been following a gluten-free diet. Next, researchers tested participants' serum levels of interleukin-2 after they did an oral gluten challenge. The levels of interleukin-2 were higher for participants with celiac disease following the oral gluten challenge. Researchers also found these levels 'positively correlated with the WBAIL-2 results.' So, if the levels of interleukin-2 were elevated on one test, they were also elevated on the other. They also tested how the WBAIL-2 results related to the presence of gluten-specific T cells, which were higher among participants with celiac disease. They did find that the presence of these cells, as well as activated versions of these cells, correlated with the WBAIL-2 test. The researchers further found that gluten-specific T cells, activated versions of these cells, and WBAIL-2 increased after participants underwent a gluten challenge. However, one participant had lower gluten-specific CD4+ T cells and a lower WBAIL-2 test on day six. Researchers also looked at treated celiac disease participants and how the tests related to their symptoms after gluten exposure. When it came to gluten-specific T-cells, their frequency was higher in participants who experienced vomiting. The measurement of serum interleukin-2 following the gluten tolerance test was also elevated, as was the WBAIL-2 level. The WBAIL-2 level was also increased greatly for one participant who did not experience vomiting but did report severe tiredness. Further analysis also suggested that activated gluten-specific CD4+ T cells are the cells that lead to gluten-induced production of interleukin-2. The results suggest that the WBAIL-2 assay can help with celiac disease diagnosis, even when people are already following a gluten-free diet. There are some limitations to this study. For one thing, it was performed out of one area, most participants were female, and there were strict inclusion criteria, so it has a limited generalizability. It also had small sample sizes for some subgroups, which means more research may be particularly necessary in these subgroups. Since researchers did not test children or people taking immunosuppressants, more research is needed to see how well this testing method would work in these populations. Researchers also acknowledge an untested 'reproducibility across laboratories.' More research is thus needed before the WBAIL-2 assay can really be used in the clinical setting. Further, the authors did not examine the cost-effectiveness of the WBAIL-2 test and how well this would stack up against current ways of diagnosing celiac disease. Then, the test was not as accurate for some participants with a specific genotype, which means it might not work for everyone. However, the number of participants with this genotype was very small in this study, and it is possible that the level of interleukin-2 response of some participants with this genotype was just not able to be detected by the test. Overall, more research is required regarding this subtype of individuals and the use of this test. Ian Storch, DO, an osteopathic physician specializing in gastroenterology and internal medicine, and an American Osteopathic Association member, who was not involved in this study, spoke to Medical News Today about its findings. 'One limitation of this study is the poor performance in the DQ8 genetic arm, which makes up 10% of celiac patients. This will decrease the sensitivity and specificity for the control group or require HLA typing before the assay is run.' Researchers acknowledge that the serum analysis of interleukin-2 following a gluten challenge does not always line up with the results of the WBAIL-2 assay, which could have to do with the assays' differences. Shilpa Mehra Dang, MD, double board-certified in gastroenterology and internal medicine with Medical Offices of Manhattan and contributor to LabFinder, who was similarly not involved in this research, noted that 'we need to look at bigger samples to really see its clinical usefulness.' In addition to larger studies, research can also focus on more details regarding gluten-specific T cells. Celiac disease is a challenging condition to manage, and accurate diagnosis is important. Researchers suggest that examining WBAIL-2 and serum interleukin-2 after gluten consumption could allow people with celiac disease to not have to get biopsies done to confirm celiac diagnosis. The authors of this study also suggest that the WBAIL-2 assay could also become a first test among people following a gluten-free diet and help with symptom severity prediction. Storch said: 'I do not think that based on the data presented, removal of histology to confirm the diagnosis can be suggested.' Jeffrey D. Davis, DO, CMD, an osteopathic physician specializing in Family Medicine and Preventive Health and an American Osteopathic Association board member, who was not involved in the study, noted the following to MNT : 'I see potential for a commercially available rapid, simple, cost-effective laboratory test for physicians to use to assist in the accurate diagnosis of celiac disease. This study shows that especially in adults already on a gluten-free diet using this lab test versus currently available tests would improve our diagnostic capabilities for Celiac Disease. However, it would most likely be just another tool in our tool box to aid in the diagnosis along with other current diagnostic methods.'
Daily Mail
5 hours ago
- Daily Mail
Father's Day treats contain 'reckless' sugar levels, shoppers warned
Retailers are packing their Father's Day chocolate ranges with record levels of sugar and calories – putting dads at risk of a host of health conditions. An analysis found some paternal-themed bars and treats include almost a week's worth of sugar in a single item. Critics and nutritionists blasted the use of 'humour' and 'oversized packaging' to target men with products that pose 'real health risks'. As part of their Father's Day range Morrisons offers a 360-gram Toblerone Milk Chocolate Bar packing a worrying 216 grams of sugar or the equivalent of 54 teaspoons of sugar, plus an astonishing 1,822 calories. NHS experts say the average adult should consume no more than 30 grams of sugar a day or seven teaspoons worth - plus a maximum 2,500 calories for a man. High-sugar diets lead to having too many calories, which leads to weight gain, while being overweight increases your risk of heart problems such as heart disease, some cancers and type 2 diabetes. And similar levels of sugar were found in treats from rival chains. Marks & Spencer says its 'Big Daddy bar' has been recognised as 'the UK's answer to Dubai chocolate' - a popular bar filled with pistachio - thanks to its 'irresistible pistachio flavour '. But nutritional information for the treat posted online shows it packs an extremely high 119 grams of sugar - the same as 30 teaspoons and more than four days' worth, plus a waist-expanding 1,500 calories. Sainsbury's offers 200-gram box of Lindt Lindor Pistachio Milk Chocolate Truffles as part of its Father's Day range. But small print on the supermarket giant's website confirms the 'bliss' inducing treat packs a hefty 84 grams of sugar – that equates to 21 teaspoons of sugar or three days' worth - plus 1,252 calories. Paul Evans, registered nutritionist at The Nutritionist UK, said: 'The levels of sugar being packed into these so-called 'Father's Day treats' are not just excessive — they're reckless. 'We're talking about single products containing nearly a week's worth of sugar, sold under the guise of a novelty gift. 'This is indulgence pushed to the point of absurdity. There's a worrying trend in how food brands target men — using humour, oversized packaging, and 'treat culture' to disguise the fact these products pose very real health risks' Elsewhere, Tesco is selling its own Toblerone themed treat designed to give dad's waistline a battering. The 400-gram Toblerone Tiny Milk, white and dark Chocolate Bars Pouch includes a tooth decay inducing 163 grams of sugar or the same as 40 teaspoons of sugar. That's almost six days' worth of the white stuff. The 35 Toblerone treats per bag specials also includes an eye-watering 1,476 calories. Tesco said: 'From grooming kits to books, we offer a great range of affordable products in store and online to help families celebrate Father's Day this year.' Mondelez International, makers of Toblerone added: 'These products are intended as an occasional treat and are clearly labelled to ensure they can be consumed as part of a healthy and balanced diet. 'We offer a wide range of different products and sizes to suit the varied needs of our consumers, each of which have nutritional information on pack. All other supermarkets were contacted for comment.
